XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
ASSETS    
Investments at fair value $ 9,626,202 $ 9,617,248
Cash and cash equivalents 103,025 131,272
Deferred financing costs 14,558 13,332
Receivable for investments sold 26,667 49,269
Total assets 9,847,992 9,908,995
LIABILITIES    
Debt (net of unamortized debt issuance costs of $32,740 and $35,289 at March 31, 2023 and December 31, 2022, respectively) 5,451,854 5,527,715
Payable for investments purchased 6,864 20,273
Due to affiliates 13,800 10,809
Management fees payable (Note 3) 18,522 18,595
Income based incentive fees payable (Note 3) 26,051 24,773
Capital gains incentive fees payable (Note 3) 3,949 5,506
Interest payable 20,178 45,289
Distribution payable 112,400 96,218
Accrued expenses and other liabilities 3,878 851
Total liabilities 5,657,496 5,750,029
Commitments and contingencies (Note 7)
NET ASSETS    
Common shares, $0.001 par value (unlimited shares authorized; 160,571,371 and 160,362,861 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively) 162 160
Additional paid in capital 4,038,243 4,033,113
Distributable earnings (loss) 152,091 125,693
Total net assets 4,190,496 4,158,966
Total liabilities and net assets $ 9,847,992 $ 9,908,995
Net asset (in usd per share) $ 26.10 $ 25.93
Non-controlled/non-affiliated investments    
ASSETS    
Investments at fair value $ 9,574,259 [1] $ 9,560,664 [2],[3]
Interest receivable from non-controlled/non-affiliated investments 77,540 97,874
Non-controlled/affiliated investments    
ASSETS    
Investments at fair value $ 51,943 [1] $ 56,584 [2],[3]
[1] Unless otherwise indicated, all debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of March 31, 2023, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company’s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.
[2] These debt investments are not pledged as collateral under any of the Company's credit facilities. For other debt investments that are pledged to the Company's credit facilities, a single investment may be divided into parts that are individually pledged as collateral to separate credit facilities. Any other debt investments listed above are pledged to financing facilities and are not available to satisfy the creditors of the Company.
[3] Unless otherwise indicated, all debt and equity investments held by the Company (which such term “Company” shall include the Company’s consolidated subsidiaries for purposes of this Consolidated Schedule of Investments) are denominated in dollars. As of December 31, 2022, the Company had investments denominated in Canadian Dollars (CAD), Euros (EUR), British Pounds (GBP), Danish Krone (DKK), Swedish Krona (SEK), and Norwegian Krone (NOK). All debt investments are income producing unless otherwise indicated. All equity investments are non-income producing unless otherwise noted. Certain portfolio company investments are subject to contractual restrictions on sales. The total par amount (in thousands) is presented for debt investments, while the number of shares or units (in whole amounts) owned is presented for equity investments. Each of the Company’s investments is pledged as collateral, under one or more of its credit facilities unless otherwise indicated.